Modern biologics and cell therapy programs increasingly rely on workflows that can generate high-quality cell lines and physiologically relevant 3D models with both speed and reproducibility. Yet many laboratories continue to experience bottlenecks rooted in manual processes, heterogeneous culture formats, and fragmented instrumentation. These challenges introduce variability, constrain throughput, and make it difficult to compare results across experiments or sites.

Scientists have engineered strains of a naturally occurring beneficial gut bacterium into a programmable “living medicine” to treat hepatic encephalopathy, a severe brain dysfunction linked to liver failure.

Hydrogen is often described as the fuel of the future — a clean, energy-dense way to store renewable power and decarbonize industries from steelmaking to shipping. But inside the devices that produce it, a surprisingly small and familiar phenomenon is getting in the way: bubbles.

Methanol is a key starting material for chemical products. Researchers from ETH Zurich can now produce this precursor from CO2 and hydrogen with high efficiency by using isolated metal atoms as catalysts.

Why did mollusks survive Earth’s largest mass extinction while many brachiopods disappeared? A Stanford-led study links the unequal losses to differences in metabolic tolerance, showing how rapidly warming, oxygen-poor oceans reshaped marine life 252 million years ago.

Vehicle-to-grid technology could give electric vehicles a second role beyond transport: stabilising the power system. A new study suggests that EVs can act as a distributed storage network, absorbing surplus renewable electricity and feeding it back into the grid at peak times.

Soft, stretchable and adhesive bioelectronics could bring wearable and implantable biosensors closer to long-term medical use. New Caltech studies show how flexible materials, wet-tissue adhesion and closed-loop sensing platforms may enable continuous monitoring and adaptive therapy inside and outside the body.

Researchers have developed a new drug – elraglusib that may help pancreatic cancer patients to live longer. A phase 2 randomized trial showed that the drug along with chemotherapy reduced the risk of death by 38 %.

What began as a failed control experiment has led to a potentially important advance in drug chemistry. Researchers at the University of Cambridge discovered a light-driven reaction that enables late-stage modification of complex drug molecules under mild conditions.

Human imagination still outperforms artificial intelligence when it comes to genuine visual creativity. A new study led by the University of Barcelona found that even advanced image-generating AI systems lag far behind both artists and non-artists in producing truly original and compelling images, especially when human guidance is removed.